At Nuvamid, we are proud to partner with Imalia, combining our innovative preclinical discoveries with their expertise in clinical development to accelerate the journey from bench to bedside. This collaboration reflects our shared commitment to advancing groundbreaking science and delivering transformative therapies to patients in need.

By leveraging Nuvamid’s cutting-edge research and platform technologies alongside Imalia’s experience in clinical trial design, regulatory navigation, and commercialization, we aim to:

• Translate early-stage breakthroughs into viable treatments through rigorous clinical validation.
• Streamline development timelines, reducing the gap between discovery and patient access.

• Address complex unmet medical needs with precision and a patient-centric approach.